Makbule Fulya Tutar Selçuk
Research Subjects
Research Interests
Makbule Fulya Tutar Selçuk has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ayca Bilginoglu
Department of Biophysics, Faculty of Medicine, Ankara Yildirim Beyazit University, 06800 Ankara, Türkiye
1 shared publication Ayça Bi̇lGi̇nOğlu
Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Biophysics, Ankara, Turkey
1 shared publication- Hilal Nakkaş
Department of Histology and Embryology, Faculty of Medicine, Ankara Yildirim Beyazit University, 06800 Ankara, Türkiye
1 shared publication - Şeyma Kipel
ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ
1 shared publication
Latest Publications
- 15 September 2026
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 9 (5) , 176-185
Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP
Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and p
- 15 September 2026
- Published by Ordu University in Black Sea Journal of Health Science
- Vol. 9 (5) , 176-185
Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP
Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and p
- Open Access
- 30 September 2022
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 3 (3) , 241-246
Effect of pioglitazone on oxidative stress of skeletal muscle in the insulin resistance rat model induced by high sucrose diet
Background: Metabolic syndrome is associated with some medical disorders such as central obesity, being overweight, insulin resistance and hypertension. This study was designed to determine the effect of pioglitazone on oxidative stress in the insulin resistance rat model.Methods: In this study, the model was induced by high sucrose (935 mm) diet for 20 weeks. Three groups were used in the experiment. Control group received standard laboratory diet and drinking water. Metabolic syndrome induced group received 32% sucrose containing drinking water for 20 weeks. Pioglitazone-treated metabolic syndrome group has received pioglitazone treatment (30 mg/kg/day, via oral gavage) for two weeks at the end of the 18th week of metabolic syndrome group. After experimental period, skeletal muscle tissues were homogenized to measure important enzymes such as aspartate aminotransferase, lactate dehydrogenase and as the marker of oxidative stress; total-antioxidant-status, total-oxidant-status and malondialdehyde. Western blot technique was used to determine protein level of thioredoxin1.Results: Aspartate aminotransferase and lactate dehydrogenase levels increased in metabolic syndrome group but pioglitazone treatment decreased these levels. In metabolic syndrome group the oxidative stress status increased but the treatment of pioglitazone decreased the level of oxidative stress in the skeletal muscle. In addition, thioredoxin1 decreased in metabolic syndrome group but administration of pioglitazone increased this level.Conclusions: There was an elevated effect of oxidative stress in high sucrose fed rats but the treatment of pioglitazone improved glucose tolerance and insulin sensitivity.
- 30 September 2022
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 3 (3) , 241-246
Open AccessEffect of pioglitazone on oxidative stress of skeletal muscle in the insulin resistance rat model induced by high sucrose diet
Background: Metabolic syndrome is associated with some medical disorders such as central obesity, being overweight, insulin resistance and hypertension. This study was designed to determine the effect of pioglitazone on oxidative stress in the insulin resistance rat model.Methods: In this study, the model was induced by high sucrose (935 mm) diet for 20 weeks. Three groups were used in the experiment. Control group received standard laboratory diet and drinking water. Metabolic syndrome induced group received 32% sucrose containing drinking water for 20 weeks. Pioglitazone-treated metabolic syndrome group has received pioglitazone treatment (30 mg/kg/day, via oral gavage) for two weeks at the end of the 18th week of metabolic syndrome group. After experimental period, skeletal muscle tissues were homogenized to measure important enzymes such as aspartate aminotransferase, lactate dehydrogenase and as the marker of oxidative stress; total-antioxidant-status, total-oxidant-status and malondialdehyde. Western blot technique was used to determine protein level of thioredoxin1.Results: Aspartate aminotransferase and lactate dehydrogenase levels increased in metabolic syndrome group but pioglitazone treatment decreased these levels. In metabolic syndrome group the oxidative stress status increased but the treatment of pioglitazone decreased the level of oxidative stress in the skeletal muscle. In addition, thioredoxin1 decreased in metabolic syndrome group but administration of pioglitazone increased this level.Conclusions: There was an elevated effect of oxidative stress in high sucrose fed rats but the treatment of pioglitazone improved glucose tolerance and insulin sensitivity.